Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe Publications section now explains that publications are automatically filled from PubMed, and the page displays Revision: v3.3.2; the previous PubMed wording and Revision: v3.2.0 have been replaced.SummaryDifference0.1%

- Check11 days agoChange DetectedRemoved the government funding status notice banner from the page, with the rest of the study details remaining visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNo substantive changes to the study page were detected between the two screenshots; core content such as study design, eligibility criteria, primary and secondary outcomes, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%

- Check61 days agoChange DetectedReplace 'Plasma cell myeloma' with 'Multiple myeloma' and increment version from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page version is updated from v3.0.1 to v3.0.2, and the Back to Top link has been removed.SummaryDifference0.1%

Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.